Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Olympus Corp ADR (OCPNY)

Olympus Corp ADR (OCPNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 27,726,932
  • Shares Outstanding, K 1,299,294
  • Annual Sales, $ 6,867 M
  • Annual Income, $ 121,430 K
  • 60-Month Beta 0.69
  • Price/Sales 4.10
  • Price/Cash Flow 25.59
  • Price/Book 7.85
Trade OCPNY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.31
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/04/21
  • Annual Dividend & Yield 0.16 (0.72%)
  • Most Recent Dividend 0.080 on 03/29/21
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.19
  • Number of Estimates 1
  • High Estimate 0.19
  • Low Estimate 0.19
  • Prior Year N/A
  • Growth Rate Est. (year over year) -99.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.1700 +5.80%
on 08/30/21
22.6200 -5.66%
on 09/16/21
+0.5900 (+2.84%)
since 08/20/21
3-Month
19.0600 +11.96%
on 07/19/21
22.6200 -5.66%
on 09/16/21
+0.0600 (+0.28%)
since 06/18/21
52-Week
18.1200 +17.77%
on 02/01/21
22.9900 -7.18%
on 12/04/20
+0.9700 (+4.76%)
since 09/18/20

Most Recent Stories

More News
Fluid Management System Market Increasing Demand with Leading Player, Comprehensive Analysis, Forecast 2028

The global size is expected to reach USD 25.5 billion by 2028 according to a new study by . Worldwide Fluid Management System Market Analysis, 2021 research report portrays a profound plunge of market...

BAX : 82.29 (-1.58%)
ECL : 217.09 (-0.57%)
HOLX : 76.73 (-1.16%)
MDT : 128.73 (-0.75%)
OCPNY : 21.3400 (-1.98%)
SYK : 268.33 (-1.72%)
Olympus Makes SeleCT™ QCT Analysis Available Nationwide via the Nuance AI Marketplace to Increase Access to Spiration Valve System Therapy

/PRNewswire/ -- Olympus Corporation today announced the launch of SeleCT Connect™, a new program offering of its SeleCT™ Quantitative Computer Tomography (QCT) analysis service available immediately...

OCPNY : 21.3400 (-1.98%)
NUAN : 55.18 (+0.15%)
Olympus to Support Endoscopic AI Diagnosis Education for Doctors in Thailand

Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) took part in a ground-breaking project as a business promoter, in cooperation with the Ministry of Internal Affairs...

OCPNY : 21.3400 (-1.98%)
Emphysema Foundation of America and Olympus Collaborate on Virtual Lung Health Education Series

and , /PRNewswire/ -- The Emphysema Foundation of America (EFA) and medical device corporation Olympus Corporation of the Americas will partner in providing a virtual lung health education series on...

OCPNY : 21.3400 (-1.98%)
Mycoplasma Testing Global Market Report 2021: COVID-19 Growth And Change

Reportlinker.com announces the release of the report "Mycoplasma Testing Global Market Report 2021: COVID-19 Growth And Change" - https://www.reportlinker.com/p06103730/?utm_source=GNW

ATRC : 72.59 (-5.37%)
CRL : 433.05 (-1.68%)
CNMD : 128.98 (-0.81%)
MKKGY : 45.6950 (-0.94%)
OCPNY : 21.3400 (-1.98%)
SNN : 36.24 (-1.60%)
Live Cell Imaging Global Market Report 2021: COVID-19 Growth And Change

Reportlinker.com announces the release of the report "Live Cell Imaging Global Market Report 2021: COVID-19 Growth And Change" - https://www.reportlinker.com/p06103737/?utm_source=GNW

OCPNY : 21.3400 (-1.98%)
PKI : 183.94 (-1.93%)
SARTF : 821.0000 (+3.24%)
FH ORTHO, Recently Acquired by Olympus, Announces Market Launch of Telegraph Evolution for Humeral Fracture Treatment

/PRNewswire/ -- Today, Olympus Corporation of the Americas announced market availability of its 510(k)-cleared Telegraph Evolution® surgical nail system from FH ORTHO, a company that Olympus acquired...

OCPNY : 21.3400 (-1.98%)
Dental Obturators Market 2021 | Size, Share, Growth, Analysis, Trends, Competitive Landscape, Revenue, Forecast Report

Growing concerns over post-surgery cosmetic appearance will drive the global dental obturators market, points out Fortune Business Insights in its report, titled "Dental Obturators Market Size, Share and...

OCPNY : 21.3400 (-1.98%)
TFX : 379.11 (-1.68%)
Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth

Olympus Corporation ("Olympus" - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has finalized the acquisition of Israeli medical device company Medi-Tate...

OCPNY : 21.3400 (-1.98%)
FH ORTHO, Recently Acquired by Olympus, Announces First Case Using e-ORTHO Shoulder Software

, /PRNewswire/ -- Today, Olympus Corporation of the Americas announced successful completion of a first use case of the 510(k) cleared e-ORTHO Shoulder software created by FH ORTHO, a company that Olympus...

OCPNY : 21.3400 (-1.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 22.2733
2nd Resistance Point 22.0667
1st Resistance Point 21.7033
Last Price 21.3400
1st Support Level 21.1333
2nd Support Level 20.9267
3rd Support Level 20.5633

See More

52-Week High 22.9900
Last Price 21.3400
Fibonacci 61.8% 21.1297
Fibonacci 50% 20.5550
Fibonacci 38.2% 19.9803
52-Week Low 18.1200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar